Severe acute asthma at the pediatric intensive care unit: can we link the clinical phenotypes to immunological endotypes?

References

• Boeschoten SA, Buysse CMP, Merkus P, et al. Children with severe acute asthma admitted to Dutch PICUs: a changing landscape. Pediatr Pulmonol. 2018;53:857–865.
   PubMedGoogle Scholar
• Hartman ME, Linde-Zwirble WT, Angus DC, et al. Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period. Pediatrics. 2010;126:e904–911.
   PubMed Web of Science ®Google Scholar
• Al-Eyadhy AA, Temsah MH, Alhaboob AA, et al. Asthma changes at a pediatric intensive care unit after 10 years: observational study. Ann Thorac Med. 2015;10:243–248.
   PubMed Web of Science ®Google Scholar
• Boeschoten SA, Boehmer AL, Merkus PJ, et al. Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study. ERJ Open Res. 2020;6:00126–2020.
   PubMedGoogle Scholar
• Moorman JE, Akinbami LJ, Bailey CM, et al. National surveillance of asthma: United States, 2001-2010. Vital Health Stat. 2012;3:1–58.
   Google Scholar
• Szefler SJ, Zeiger RS, Haselkorn T, et al. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2011;107:110–119 e111.
   PubMed Web of Science ®Google Scholar
• Grunwell JR, Travers C, Fitzpatrick AM. Inflammatory and comorbid features of children admitted to a PICU for status asthmaticus. Pediatr Crit Care Med. 2018;19:e585–e594.
   PubMed Web of Science ®Google Scholar
• Boeschoten SA, Dulfer K, Boehmer ALM, et al., Dutch collaborative PrnAclornpipita. Quality of life and psychosocial outcomes in children with severe acute asthma and their parents. Pediatr Pulmonol. 2020;55:2883–2892.
   Web of Science ®Google Scholar
• Rees G, Gledhill J, Garralda ME, et al. Psychiatric outcome following paediatric intensive care unit (PICU) admission: a cohort study. Intensive Care Med. 2004;30:1607–1614.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Moore WC. Severe asthma phenotypes - How should they guide evaluation and treatment? J Allergy Clin Immunol Pract. 2017;5:901–908.
   PubMed Web of Science ®Google Scholar
• Licari A, Manti S, Castagnoli R, et al. Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice. Breathe (Sheff). 2020;16:190301.
   PubMedGoogle Scholar
• Bush A. Which child with asthma is a candidate for biological therapies? J Clin Med. 2020 9 ;1237.
   Web of Science ®Google Scholar
• Goodwin R, Chander T, Shah N, et al. Inhaler counselling, the real deal or just fresh air? Arch Dis Child. 2016;101:e2.
   PubMedGoogle Scholar
• Bush A, Saglani S, Fleming L. Severe asthma: looking beyond the amount of medication. Lancet Respir Med. 2017;5:844–846.
   PubMed Web of Science ®Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–373.
   PubMed Web of Science ®Google Scholar
• van Den Bosch GE, Merkus PJ, Buysse CM, et al. Risk factors for pediatric intensive care admission in children with acute asthma. Respir Care. 2012;57:1391–1397.
   PubMed Web of Science ®Google Scholar
• Belessis Y, Dixon S, Thomsen A, et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol. 2004;37:201–209.
   PubMed Web of Science ®Google Scholar
• McDowell KM, Kercsmar CM, Huang B, et al. Medical and social determinants of health associated with intensive care admission for asthma in children. Ann Am Thorac Soc. 2016;13:1081–1088.
   PubMed Web of Science ®Google Scholar
• Arroyo AJC, Chee CP, Camargo CA Jr., et al. Where do children die from asthma? National data from 2003 to 2015. J Allergy Clin Immunol Pract. 2018;6:1034–1036.
   PubMed Web of Science ®Google Scholar
• Guilbert T, Zeiger RS, Haselkorn T, et al. Racial disparities in asthma-related health outcomes in children with severe/difficult-to-treat asthma. J Allergy Clin Immunol Pract. 2019;7:568–577.
   PubMed Web of Science ®Google Scholar
• Puranik S, Forno E, Bush A, et al. Predicting severe asthma exacerbations in children. Am J Respir Crit Care Med. 2017;195:854–859.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Stoltz P, Raykov N, et al. Childhood overweight increases hospital admission rates for asthma. Pediatrics. 2007;120:734–740.
   PubMed Web of Science ®Google Scholar
• Weinmayr G, Forastiere F, Buchele G, et al. Overweight/obesity and respiratory and allergic disease in children: international study of asthma and allergies in childhood (ISAAC) phase two. PLoS One. 2014;9:e113996.
   PubMed Web of Science ®Google Scholar
• Bush A, Fleming L, Saglani S. Severe asthma in children. Respirology. 2017;22:886–897.
   PubMed Web of Science ®Google Scholar
• Forno E, Lescher R, Strunk R, et al. Childhood Asthma Management Program Research Group. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127:741–749.
   PubMed Web of Science ®Google Scholar
• Periyalil HA, Wood LG, Scott HA, et al. Macrophage activation, age and sex effects of immunometabolism in obese asthma. Eur Respir J. 2015;45:388–395.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Sala KA, Zucker AR, et al. beta2-adrenergic receptor haplotype linked to intubation and mechanical ventilation in children with asthma. J Asthma. 2012;49:563–568.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Sala KA, Zucker AR, et al. Beta-adrenergic receptor polymorphisms associated with length of ICU stay in pediatric status asthmaticus. Pediatr Pulmonol. 2012;47:233–239.
   PubMed Web of Science ®Google Scholar
• Carroll CL, Stoltz P, Schramm CM, et al. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations. Chest. 2009;135:1186–1192.
   PubMed Web of Science ®Google Scholar
• Bossley CJ, Fleming L, Ullmann N, et al. Assessment of corticosteroid response in pediatric patients with severe asthma by using a multidomain approach. J Allergy Clin Immunol. 2016;138:413–420 e416.
   PubMed Web of Science ®Google Scholar
• Chung KF, Adcock IM. Precision medicine for the discovery of treatable mechanisms in severe asthma. Allergy. 2019;74:1649–1659.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Ora J, Cavalli F, et al. Treatable mechanisms in asthma. Mol Diagn Ther. 2021;25:111–121.
   PubMed Web of Science ®Google Scholar
• Andersson CK, Adams A, Nagakumar P, et al. Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function. J Allergy Clin Immunol. 2017;139:1819–1829 e1811.
   PubMed Web of Science ®Google Scholar
• Bousquet J. Stratification of patients with severe asthma. Lancet Respir Med. 2015;3:330–331.
   PubMed Web of Science ®Google Scholar
• Hamzaoui A, Berraies A, Kaabachi W, et al. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma. 2013;50:803–809.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang J, Gao P. The potential of interleukin-37 as an effective therapeutic agent in asthma. Respir Res. 2017;18:192.
   PubMed Web of Science ®Google Scholar
• Charrad R, Berraies A, Hamdi B, et al. Anti-inflammatory activity of IL-37 in asthmatic children: correlation with inflammatory cytokines TNF-alpha, IL-beta, IL-6 and IL-17A. Immunobiology. 2016;221:182–187.
   PubMed Web of Science ®Google Scholar
• Zissler UM, Jakwerth CA, Guerth F, et al. Allergen-specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways. Allergy. 2021;76:2461–2474.
   PubMed Web of Science ®Google Scholar
• Zhu L, An L, Ran D, et al. The club cell marker SCGB1A1 downstream of FOXA2 is reduced in asthma. Am J Respir Cell Mol Biol. 2019;60:695–704.
   PubMed Web of Science ®Google Scholar
• Teague WG, Lawrence MG, Shirley DT, et al. Lung lavage granulocyte patterns and clinical phenotypes in children with severe, therapy-resistant asthma. J Allergy Clin Immunol Pract. 2019;7:1803–1812 e1810.
   PubMed Web of Science ®Google Scholar
• Steinke JW, Lawrence MG, Teague WG, et al. Bronchoalveolar lavage cytokine patterns in children with severe neutrophilic and paucigranulocytic asthma. J Allergy Clin Immunol. 2021;147:686–693 e683.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AM, Higgins M, Holguin F, et al.; National Institutes of Health/National Heart L, Blood Institute’s Severe Asthma Research P. The molecular phenotype of severe asthma in children. J Allergy Clin Immunol. 2010;125:851–857 e818.
   PubMed Web of Science ®Google Scholar
• Grunwell JR, Stephenson ST, Tirouvanziam R, et al. Children with neutrophil-predominant severe asthma have proinflammatory neutrophils with enhanced survival and impaired clearance. J Allergy Clin Immunol Pract. 2019;7:516–525 e516.
   PubMed Web of Science ®Google Scholar
• Belvisi MG. Regulation of inflammatory cell function by corticosteroids. Proc Am Thorac Soc. 2004;1:207–214.
   PubMedGoogle Scholar
• Schleimer RP. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 1990;141:S59–69.
   PubMedGoogle Scholar
• Nagakumar P, Puttur F, and Gregory LG, et al. Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids. Eur Respir J. 2019 54 2 ;1801809.
   PubMed Web of Science ®Google Scholar
• Shah SP, Grunwell J, Shih J, et al. Exploring the utility of noninvasive type 2 inflammatory markers for prediction of severe asthma exacerbations in children and adolescents. J Allergy Clin Immunol Pract. 2019;7:2624–2633 e2622.
   PubMed Web of Science ®Google Scholar
• Baumann R, Untersmayr E, Zissler UM, et al. Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases. Allergy. 2021;76:1010–1023.
   PubMed Web of Science ®Google Scholar
• Peters MC, Mekonnen ZK, Yuan S, et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133(388–394):388–394.e5.
   PubMedGoogle Scholar
• Nagakumar P, Denney L, Fleming L, et al. Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol. 2016;137:624–626 e626.
   PubMed Web of Science ®Google Scholar
• Baigelman W, Chodosh S, Pizzuto D, et al. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med. 1983;75:929–936.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Grootendor DC, Henry RL, et al. Sputum induction in children. Eur Respir J Suppl. 2002;37:44s–46s.
   PubMedGoogle Scholar
• Bal SM, Golebski K, Spits H. Plasticity of innate lymphoid cell subsets. Nat Rev Immunol. 2020;20::552–565.
   PubMed Web of Science ®Google Scholar
• Golebski K, Layhadi JA, Sahiner U, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. 2021;54:291–307 e297.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Hepworth MR. Functional interactions between innate lymphoid cells and adaptive immunity. Nat Rev Immunol. 2019;19:599–613.
   PubMed Web of Science ®Google Scholar
• Castanhinha S, Sherburn R, Walker S, et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol. 2015;136:312–322 e317.
   PubMed Web of Science ®Google Scholar
• Hussain SMA, Sen A, Barraclough BC, et al. Blood levels of type-2 innate lymphoid cells in preschool children with acute wheeze. Eur Respir J. 2017;50. PA1335.
   Web of Science ®Google Scholar
• Cianchetti S, Cardini C, Puxeddu I, et al. Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction. World Allergy Organ J. 2019;12:100078.
   PubMed Web of Science ®Google Scholar
• Teague WG, Phillips BR, Fahy JV, et al. Baseline features of the Severe Asthma Research Program (SARP III) cohort: differences with age. J Allergy Clin Immunol Pract. 2018;6:545–554 e544.
   PubMed Web of Science ®Google Scholar
• Wilson NM, Bridge P, Spanevello A, et al. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax. 2000;55:768–774.
   PubMed Web of Science ®Google Scholar
• van de Kant KD, van der Sande LJ, Jobsis Q, et al. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res. 2012;13:117.
   PubMed Web of Science ®Google Scholar
• Neerincx AH, Vijverberg SJH, Bos LDJ, et al. Breathomics from exhaled volatile organic compounds in pediatric asthma. Pediatr Pulmonol. 2017;52:1616–1627.
   PubMed Web of Science ®Google Scholar
• van Vliet D, Smolinska A, Jobsis Q, et al. Can exhaled volatile organic compounds predict asthma exacerbations in children? J Breath Res. 2017;11:016016.
   PubMed Web of Science ®Google Scholar
• Robroeks CM, van Berkel JJ, Jobsis Q, et al. Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Eur Respir J. 2013;42:98–106.
   PubMed Web of Science ®Google Scholar
• van Oort PM, de Bruin S, and Weda H, et al., On Behalf Of The Mars C. Exhaled breath metabolomics for the diagnosis of pneumonia in intubated and mechanically-ventilated Intensive Care Unit (ICU)-patients. Int J Mol Sci. 2017 18 2 ;449.
   Web of Science ®Google Scholar
• Hong H, Liao S, Chen F, et al. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75::2794–2804.
   PubMed Web of Science ®Google Scholar
• Zissler UM, Ulrich M, Jakwerth CA, et al. Biomatrix for upper and lower airway biomarkers in patients with allergic asthma. J Allergy Clin Immunol. 2018;142:1980–1983.
   PubMed Web of Science ®Google Scholar
• Cardenas A, Sordillo JE, Rifas-Shiman SL, et al. The nasal methylome as a biomarker of asthma and airway inflammation in children. Nat Commun. 2019;10:3095.
   PubMed Web of Science ®Google Scholar
• Bergougnoux A, Claustres M, De Sario A. Nasal epithelial cells: a tool to study DNA methylation in airway diseases. Epigenomics. 2015;7:119–126.
   PubMed Web of Science ®Google Scholar
• Zhu T, Zhang X, Chen X, et al. Nasal DNA methylation differentiates severe from non-severe asthma in African-American children. Allergy. 2021;76:1836–1845.
   PubMed Web of Science ®Google Scholar
• Goodman MA, Moradi Manesh D, Malik P, et al. CRISPR/Cas9 in allergic and immunologic diseases. Expert Rev Clin Immunol. 2017;13:5–9.
   PubMed Web of Science ®Google Scholar
• Agache I, Akdis CA, Akdis M, et al. EAACI biologicals guidelines-recommendations for severe asthma. Allergy. 2021;76:14–44.
   PubMed Web of Science ®Google Scholar
• Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136:1476–1485.
   PubMed Web of Science ®Google Scholar
• Vijverberg SJH, Brinkman P, Rutjes NWP, et al. Precision medicine in severe pediatric asthma: opportunities and challenges. Curr Opin Pulm Med. 2020;26:77–83.
   PubMed Web of Science ®Google Scholar
• Israel E, Mb H. Personalizing precision medicine. J Allergy Clin Immunol Pract. 2020;8:1614–1615.
   PubMed Web of Science ®Google Scholar
• Jang YJ, Kwon HJ, Lee BJ. Effect of clarithromycin on rhinovirus-16 infection in A549 cells. Eur Respir J. 2006;27:12–19.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Ferrara G, and Fabbri LM, et al. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2005 3 ;CD002997.
   Web of Science ®Google Scholar
• Golebski K, Kabesch M, Melen E, et al. Childhood asthma in the new omics era: challenges and perspectives. Curr Opin Allergy Clin Immunol. 2020;20:155–161.
   PubMed Web of Science ®Google Scholar
• Fleming L, Murray C, Bansal AT, et al. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts. Eur Respir J. 2015;46:1322–1333.
   PubMed Web of Science ®Google Scholar
• Ivanova O, Richards LB, Vijverberg SJ, et al. What did we learn from multiple omics studies in asthma? Allergy. 2019;74:2129–2145.
   PubMed Web of Science ®Google Scholar
• Roberts J, Bratton SL, Brogan TV. Acute severe asthma: differences in therapies and outcomes among pediatric intensive care units. Crit Care Med. 2002;30:581–585.
   PubMed Web of Science ®Google Scholar